User profiles for Fabio Ciceri
Fabio CiceriMD, Hematology BMT Unit, San Raffaele Scientific Institute Verified email at hsr.it Cited by 12402 |
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy
F Ciceri, A Castagna, P Rovere-Querini, F De Cobelli… - Clinical …, 2020 - Elsevier
Background National health-system hospitals of Lombardy faced a heavy burden of
admissions for acute respiratory distress syndromes associated with coronavirus disease (COVID-19…
admissions for acute respiratory distress syndromes associated with coronavirus disease (COVID-19…
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors
…, I Bollettini, EMT Melloni, R Furlan, F Ciceri… - Brain, behavior, and …, 2020 - Elsevier
Infection-triggered perturbation of the immune system could induce psychopathology, and
psychiatric sequelae were observed after previous coronavirus outbreaks. The spreading of …
psychiatric sequelae were observed after previous coronavirus outbreaks. The spreading of …
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non …
Background Procedures to prevent severe graft-versus-host disease (GVHD) delay immune
reconstitution secondary to transplants of haploidentical haemopoietic stem cells for the …
reconstitution secondary to transplants of haploidentical haemopoietic stem cells for the …
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
[HTML][HTML] Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort …
…, S Martinenghi, R Scotti, M Tresoldi, F Ciceri… - The Lancet …, 2020 - thelancet.com
Background Mortality of patients with coronavirus disease 2019 (COVID-19), acute respiratory
distress syndrome (ARDS), and systemic inflammation is high. In areas of pandemic …
distress syndrome (ARDS), and systemic inflammation is high. In areas of pandemic …
[HTML][HTML] Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working …
F Ciceri, L Beretta, AM Scandroglio, S Colombo… - Critical care and …, 2020 - Elsevier
We suggest the use of MicroCLOTS (microvascular COVID-19 lung vessels obstructive
thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 …
thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 …
[HTML][HTML] Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
…, G La Nasa, M Luppi, F Ciceri… - … England Journal of …, 2013 - Mass Medical Soc
Background All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for
acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of …
acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of …
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy
…, J Gardner, C Von Kalle, C Bordignon, F Ciceri… - Science, 2013 - science.org
Introduction Metachromatic leukodystrophy (MLD) is a neurodegenerative lysosomal
storage disease caused by arylsulfatase A (ARSA) deficiency. The disease primarily affects …
storage disease caused by arylsulfatase A (ARSA) deficiency. The disease primarily affects …
[HTML][HTML] Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
…, A Canitano, I Marzinotto, C Tresoldi, F Ciceri… - Nature …, 2021 - nature.com
Understanding how antibody responses to SARS-CoV-2 evolve during infection may provide
important insight into therapeutic approaches and vaccination for COVID-19. Here we …
important insight into therapeutic approaches and vaccination for COVID-19. Here we …
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome
…, MG Valsecchi, A Biffi, E Montini, A Villa, F Ciceri… - Science, 2013 - science.org
Introduction Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency characterized
by eczema, thrombocytopenia, infections, and a high risk of developing autoimmunity and …
by eczema, thrombocytopenia, infections, and a high risk of developing autoimmunity and …